COVID-19 Switzerland
Information on the current situation, as of 16 August 2022
Demography
Vaccinated people, Switzerland, 21.12.2020 to 15.08.2022
The graph shows the development of the number of vaccinated people by 10-year age group and age group under the COVID-19 vaccination strategy. A review of the data has shown that for the 0-4-year-olds the entries are mainly erroneous. We are not aware of systematic vaccinations for under 5s. For the sake of transparency we are publishing the data sent by the cantons without processing them.
The data published here is based on information provided to us regularly by the cantons and the Principality of Liechtenstein. We publish the numbers each Tuesday. Therefore, they may differ from the numbers communicated by the cantons and Liechtenstein. The figures cover vaccines from all manufacturers.
Three vaccines for preventing COVID-19 are authorised in Switzerland and Liechtenstein. People are deemed to be fully vaccinated if they have received two doses of Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) vaccine, or one dose of these vaccines after a proven infection with SARS-CoV-2. Only one dose of the Johnson & Johnson (Covid-19 Vaccine Janssen®) vaccine is required (FOPH/Federal Vaccination Commission vaccination recommendation).
A booster vaccination with an mRNA vaccine from Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) is recommended from four months following full vaccination (primary course of vaccination) for everyone aged 12 years or older (preferably Comirnaty® for those aged between 12 and 30 years). Fully vaccinated people who receive a booster vaccination in accordance with the FOPH/Federal Vaccination Commission vaccination recommendation are presented separately. The share of fully vaccinated people relates to the total population or the age group in question. Vaccinated people are allocated to the canton in which they live (canton of residence). More information can be found on FOPH website > Coronavirus: Vaccination.
Information on adverse vaccination reactions (AVRs) is collected via Swissmedic’s spontaneous reporting system. Swissmedic reviews and evaluates the reported side effects. More details can be found on the Swissmedic website.
The cantons and the Principality of Liechtenstein provide us with the data via a secure electronic channel. They are sent in the form of anonymised individual data.
Three vaccines for preventing COVID-19 are authorised in Switzerland and Liechtenstein. People are deemed to be fully vaccinated if they have received two doses of Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) vaccine, or one dose of these vaccines after a proven infection with SARS-CoV-2. Only one dose of the Johnson & Johnson (Covid-19 Vaccine Janssen®) vaccine is required (FOPH/Federal Vaccination Commission vaccination recommendation).
A booster vaccination with an mRNA vaccine from Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) is recommended from four months following full vaccination (primary course of vaccination) for everyone aged 12 years or older (preferably Comirnaty® for those aged between 12 and 30 years). Fully vaccinated people who receive a booster vaccination in accordance with the FOPH/Federal Vaccination Commission vaccination recommendation are presented separately. The share of fully vaccinated people relates to the total population or the age group in question. Vaccinated people are allocated to the canton in which they live (canton of residence). More information can be found on FOPH website > Coronavirus: Vaccination.
Information on adverse vaccination reactions (AVRs) is collected via Swissmedic’s spontaneous reporting system. Swissmedic reviews and evaluates the reported side effects. More details can be found on the Swissmedic website.
The cantons and the Principality of Liechtenstein provide us with the data via a secure electronic channel. They are sent in the form of anonymised individual data.
Distribution by age group
Switzerland
With booster vaccination
Fully vaccinated
Partially vaccinated
0–9
0,03%
2,86%
0,85%
10–19
14,87%
49,17%
1,78%
20–29
32,71%
71,52%
1,14%
30–39
38,32%
73,29%
1,01%
40–49
46,05%
77,31%
0,87%
50–59
54,87%
80,54%
0,77%
60–69
68,39%
86,18%
0,68%
70–79
79,26%
90,91%
0,65%
80+
82,42%
94,55%
1,27%
Share of fully vaccinated people
0,01%9,7%
No fully vaccinated people